Study of medicines for skin-only vasculitis flares
Treatments studied
Part of Blood & lymphatic, Heart & circulation, Immune system & allergy, Skin clinical trials.
This Phase 2 trial tests different medicines to calm active skin vasculitis and prevent flare-ups. It’s for people whose vasculitis mainly affects the skin, not major organs like kidneys or the brain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your vasculitis is mainly on the skin (small- or medium-vessel skin vasculitis, cutaneous polyarteritis nodosa, or IgA vasculitis with no active kidney disease).
- A skin biopsy already confirmed vasculitis, with special staining done (immunofluorescence for small-vessel cases).
- You have active skin lesions now, and symptoms have lasted at least 1 month or you’ve had 2+ flares in the last 6 months.
- If you have IgA vasculitis, your kidney function is stable: GFR over 60 and only mild, stable urine blood/protein (and you don’t need stronger whole-body immune medicine for the kidneys).
- You’re age 18 or older.
- You can safely take the study medicines (no serious liver/kidney problems, low blood counts, or pregnancy/breastfeeding; no major infection).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a skin biopsy to look at “gene signals” (transcriptomics) in patients with active vasculitis that shows up on the skin. It may help researchers understand what is happening in your disease and how different types of vasculitis differ.
This study looks at treatment strategies for children with IgA vasculitis (also called Henoch-Schönlein purpura) when it mainly affects the stomach and intestines and symptoms do not improve with standard steroid dosing. It may help find better ways to control the illness early and prevent serious complications.
This observational study follows adults with vasculitis (inflammation of blood vessels) during an active flare or relapse. It aims to better understand how the disease changes over time and may help researchers plan future treatments.
This trial tests lower steroid doses for people with certain types of vasculitis that have newly affected their kidneys. The goal is to find out if a lower dose works just as well with fewer side effects.
This study looks at different types of blood vessel inflammation (vasculitis) to learn more about why they happen and how they progress. By joining, you may help doctors better understand these conditions and improve future treatments.
This study compares different sequences of medicines for treating severe ulcerative colitis flares in the hospital. It aims to find the best way to get your symptoms under control and help you feel better faster.
Hear when a new IgA Vasculitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.